Carole Ho insider trades: Denali Therapeutics (DNLI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Carole reports to the SEC
Open-market buys and sales
53 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | DNLI | ↓ Sell | 3,743 | $13.81 | $52K | Direct | Aug 14, 2025 (1d) |
| Jan 7, 2025 | DNLI | ↓ Sell | 15,162 | $20.33 | $308K | Direct | Jan 8, 2025 (1d) |
| Aug 21, 2024 | DNLI | ↓ Sell | 22,458 | $24.49 | $550K | Direct | Aug 22, 2024 (1d) |
| Aug 13, 2024 | DNLI | ↓ Sell | 2,337 | $22.89 | $53K | Direct | Aug 15, 2024 (2d) |
| Feb 14, 2024 | DNLI | ↓ Sell | 4,189 | $17.46 | $73K | Direct | Feb 15, 2024 (1d) |
| Jan 10, 2024 | DNLI | ↓ Sell | 4,668 | $19.02 | $89K | Direct | Jan 12, 2024 (2d) |
| Jan 5, 2024 | DNLI | ↓ Sell | 9,972 | $19.43 | $194K | Indirect | Jan 9, 2024 (4d) |
| Aug 23, 2023 | DNLI | ↓ Sell | 2,522 | $23.22 | $59K | Indirect | Aug 25, 2023 (2d) |
| Aug 21, 2023 | DNLI | ↓ Sell | 2,478 | $22.60 | $56K | Indirect | Aug 23, 2023 (2d) |
| Aug 14, 2023 | DNLI | ↓ Sell | 2,768 | $23.79 | $66K | Indirect | Aug 16, 2023 (2d) |
| Aug 10, 2023 | DNLI | ↓ Sell | 2,857 | $24.15 | $69K | Indirect | Aug 14, 2023 (4d) |
| Feb 15, 2023 | DNLI | ↓ Sell | 1,476 | $29.40 | $43K | Indirect | Feb 17, 2023 (2d) |
| Feb 13, 2023 | DNLI | ↓ Sell | 3,366 | $30.03 | $101K | Indirect | Feb 14, 2023 (1d) |
| Feb 8, 2023 | DNLI | ↓ Sell | 1,521 | $30.88 | $47K | Indirect | Feb 10, 2023 (2d) |
| Jan 9, 2023 | DNLI | ↓ Sell | 1,459 | $28.48 | $42K | Indirect | Jan 10, 2023 (1d) |
| Jan 6, 2023 | DNLI | ↓ Sell | 4,087 | $28.52 | $117K | Indirect | Jan 9, 2023 (3d) |
| Jan 4, 2023 | DNLI | ↓ Sell | 2,913 | $28.69 | $84K | Indirect | Jan 5, 2023 (1d) |
| Aug 23, 2022 | DNLI | ↓ Sell | 2,424 | $31.98 | $78K | Indirect | Aug 25, 2022 (2d) |
| Aug 19, 2022 | DNLI | ↓ Sell | 2,576 | $33.22 | $86K | Indirect | Aug 23, 2022 (4d) |
| Feb 11, 2022 | DNLI | ↓ Sell | 2,918 | $34.71 | $101K | Indirect | Feb 15, 2022 (4d) |
| Feb 9, 2022 | DNLI | ↓ Sell | 1,423 | $37.10 | $53K | Indirect | Feb 11, 2022 (2d) |
| Jan 5, 2022 | DNLI | ↓ Sell | 2,845 | $44.78 | $127K | Indirect | Jan 7, 2022 (2d) |
| Dec 6, 2021 | DNLI | ↓ Sell | 1,476 | $42.52 | $63K | Direct | Dec 8, 2021 (2d) |
| Aug 23, 2021 | DNLI | ↓ Sell | 6,143 | $48.91 | $300K | Indirect | Aug 25, 2021 (2d) |
| Aug 19, 2021 | DNLI | ↓ Sell | 2,546 | $49.58 | $126K | Indirect | Aug 23, 2021 (4d) |
| Mar 29, 2021 | DNLI | ↓ Sell | 2,822 | $54.62 | $154K | Indirect | Mar 31, 2021 (2d) |
| Mar 1, 2021 | DNLI | ↓ Sell | 7,092 | $66.38 | $471K | Indirect | Mar 3, 2021 (2d) |
| Feb 11, 2021 | DNLI | ↓ Sell | 3,156 | $70.33 | $222K | Indirect | Feb 16, 2021 (5d) |
| Feb 9, 2021 | DNLI | ↓ Sell | 1,470 | $74.68 | $110K | Indirect | Feb 11, 2021 (2d) |
| Oct 9, 2020 | DNLI | ↓ Sell | 52,906 | $40.74 | $2.2M | Indirect | Oct 13, 2020 (4d) |
| Sep 10, 2020 | DNLI | ↓ Sell | 3,689 | $31.00 | $114K | Indirect | Sep 14, 2020 (4d) |
| Mar 30, 2020 | DNLI | ↓ Sell | 1,428 | $19.48 | $28K | Direct | Apr 1, 2020 (2d) |
| Dec 23, 2019 | DNLI | ↓ Sell | 6,890 | $20.01 | $138K | Direct | Dec 23, 2019 (0d) |
| Jul 8, 2019 | DNLI | ↓ Sell | 10,989 | $20.28 | $223K | Indirect | Jul 10, 2019 (2d) |
| Jul 8, 2019 | DNLI | ↓ Sell | 6,511 | $20.30 | $132K | Direct | Jul 10, 2019 (2d) |
| Jun 10, 2019 | DNLI | ↓ Sell | 12,883 | $18.78 | $242K | Indirect | Jun 12, 2019 (2d) |
| Jun 10, 2019 | DNLI | ↓ Sell | 4,617 | $18.78 | $87K | Direct | Jun 12, 2019 (2d) |
| May 10, 2019 | DNLI | ↓ Sell | 9,688 | $22.84 | $221K | Indirect | May 10, 2019 (0d) |
| May 10, 2019 | DNLI | ↓ Sell | 7,812 | $22.87 | $179K | Direct | May 10, 2019 (0d) |
| Apr 4, 2019 | DNLI | ↓ Sell | 9,588 | $26.35 | $253K | Indirect | Apr 8, 2019 (4d) |
| Apr 3, 2019 | DNLI | ↓ Sell | 19,033 | $25.82 | $491K | Indirect | Apr 3, 2019 (0d) |
| Apr 3, 2019 | DNLI | ↓ Sell | 17,772 | $25.03 | $445K | Direct | Apr 3, 2019 (0d) |
| Mar 14, 2019 | DNLI | ↓ Sell | 500 | $25.01 | $13K | Indirect | Mar 18, 2019 (4d) |
| Mar 14, 2019 | DNLI | ↓ Sell | 500 | $25.01 | $13K | Direct | Mar 18, 2019 (4d) |
| Mar 5, 2019 | DNLI | ↓ Sell | 17,500 | $22.17 | $388K | Direct | Mar 5, 2019 (0d) |
| Feb 5, 2019 | DNLI | ↓ Sell | 17,500 | $18.72 | $328K | Direct | Feb 5, 2019 (0d) |
| Jan 4, 2019 | DNLI | ↓ Sell | 8,727 | $19.54 | $171K | Direct | Jan 4, 2019 (0d) |
| Jan 2, 2019 | DNLI | ↓ Sell | 5,775 | $19.56 | $113K | Indirect | Jan 4, 2019 (2d) |
| Dec 3, 2018 | DNLI | ↓ Sell | 17,500 | $18.45 | $323K | Indirect | Dec 6, 2018 (3d) |
| Nov 15, 2018 | DNLI | ↓ Sell | 17,500 | $18.07 | $316K | Indirect | Nov 19, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DNLI insiders
Open-market trades in the last 12 months
About Carole Ho's insider trades
Carole Ho is Chief Medical Officer at Denali Therapeutics (DNLI). Since Aug 29, 2018, Carole has reported no open-market purchases and 53 sales worth $11.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), option exercises (14 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.